Corteva completed the spin-off of its seed and genetics business into Vylor Inc. on October 1, 2026, following a federal court ruling that cleared a last-minute legal challenge from California. The corporate split transfers Vylor’s value into a newly traded New York Stock Exchange entity under the ticker VYLR, leaving Corteva as a pure-play crop protection company.
Federal Court Clears Vylor Spin-Off After California Files Late Challenge
The corporate separation proceeded on October 1, 2026, following a swift legal battle in the federal court system. On September 30, a district court order that had previously denied the State of California permission to file a motion seeking a temporary restraining order and preliminary injunction was overturned by the U.S. Court of Appeals for the Fourth Circuit. California had sought to delay the transaction over potential environmental liabilities.
District Court denied California’s request, citing the state’s late filing just 17 days before the scheduled distribution. The appeals court returned the matter to the district court without expressing a view on the merits of the state’s motion, while dismissing the request for an injunction pending appeal as moot.
Effective September 30, the board waived the Legal Restraints Condition to the extent it was unmet solely due to potential governmental orders. Corteva’s board had already acted to remove internal procedural hurdles ahead of the deadline. The distribution was completed before 9:30 a.m. New York City time on October 1.
Shareholders Receive Vylor Stock While Debt Exchanges Fund Separation
Shareholders of record as of the close of business on September 24, 2026, were entitled to receive Vylor shares while retaining their existing holdings in Corteva. Under the terms approved by Corteva’s board on September 12, the distribution was executed as a pro rata dividend of Vylor common stock carrying a par value of $0.01 per share. The Form 8-K detailing these actions was co-filed by Corteva and EIDP, Inc., and signed by Senior Vice President and Chief Legal and Public Affairs Officer Jennifer A. Johnson.
Participating investors received corresponding Vylor notes matching the original interest rates and maturity schedules. Parallel to the stock distribution, Vylor completed private debt exchange offers tied to the separation. EIDP’s 2.300% senior notes due 2030 were tendered by eligible holders in the amount of $434.8 million, alongside $476.2 million of its 5.125% notes due 2032 and $527.6 million of its 4.800% notes due 2033.
Vylor Debuts on Exchange as Corteva Stock Price Drops
Vylor officially began trading on October 1, 2026, under the ticker symbol “VYLR” on the New York Stock Exchange. Chuck Magro serves as chief executive officer of the newly independent seed and advanced genetics enterprise. Market data from MarketBeat indicates that Corteva previously maintained an average rating of “Moderate Buy” and an average target price of $91.90, supported by a beta of 0.57 and a price-to-earnings ratio of 9.30.
“Vylor was created to redefine agriculture,”
Chuck Magro, CEO of Vylor
“And we can’t wait to get started.”
Chuck Magro, CEO of Vylor
Because the value of the seed business was spun off into Vylor, Corteva stock dropped sharply, trading down on the day of the distribution, with shares changing hands at volume totals surpassing 2.8 million. The separation triggered an immediate downward adjustment in Corteva’s share price. Financial analysts noted that the decline reflects the transfer of assets out of the parent company rather than an equivalent loss of underlying shareholder value.
Corteva Operates as Pure-Play Entity as Vylor Targets Growth
With the separation finalized, Corteva operates exclusively as a pure-play global crop protection enterprise. The company notes that roughly 65% of its sales now derive from differentiated technologies.
Vylor also expects its licensing division, Vylor One, to generate gross licensing revenue exceeding $500 million in 2027, surpassing $1 billion by 2035, and reaching nearly $2 billion by 2040. Meanwhile, Vylor enters the market anchored by a technological innovation portfolio. The company outlined multi-year targets during Investor Day presentations, projecting net sales of approximately $11.2–11.9 billion by 2029 alongside operating EBITDA of approximately $3.3–3.7 billion.